2022
DOI: 10.5603/mrj.2022.0059
|View full text |Cite
|
Sign up to set email alerts
|

Functioning in chronic disease — a key factor determining adherence to heart failure treatment

Abstract: This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 37 publications
0
0
0
Order By: Relevance
“…The project applied in the ELECTRA-SIRIO 2 trial [21,22] is aimed to support adherence to the study medication. It consists of diagnosis regarding readiness for discharge from hospital [9,23], adherence to medication [24][25][26] and functioning in chronic illness [27][28][29][30][31], individualized education [32][33][34] and motivation [18]. The results of the MEDMOTION project, planned after the completion of the one-year follow-up of 500 patients in the ELECTRA-SIRIO 2 study, are expected soon.…”
Section: To the Editormentioning
confidence: 99%
“…The project applied in the ELECTRA-SIRIO 2 trial [21,22] is aimed to support adherence to the study medication. It consists of diagnosis regarding readiness for discharge from hospital [9,23], adherence to medication [24][25][26] and functioning in chronic illness [27][28][29][30][31], individualized education [32][33][34] and motivation [18]. The results of the MEDMOTION project, planned after the completion of the one-year follow-up of 500 patients in the ELECTRA-SIRIO 2 study, are expected soon.…”
Section: To the Editormentioning
confidence: 99%
“…Obesity is a key factor impeding the physical and mental functioning of patients with MetS. The Functioning in Chronic Illness Scale (FCIS) is a unique tool developed for comprehensive evaluation of various aspects of patient functioning with chronic disease [7][8][9]. This scale, consisting of three subscales and 24 items is designed to evaluate the impact of the disease on the patient in the first subscale.…”
Section: To the Editormentioning
confidence: 99%
“…Low adherence to therapeutic plans is the main limitation of the effectiveness of therapy in obese patients. There is a direct link between the patient's functioning and adherence to treatment, therefore, all activities aimed at supporting cooperation with an obese patient are of key importance for therapy effectiveness [7,[11][12][13][14][15][16][17][18][19][20][21]. Thus, the Adherence in Chronic Disease Scale (ACDS) is also worth validating in MetS patients [22][23][24][25][26][27].…”
Section: To the Editormentioning
confidence: 99%
“…In addition, questionnaire-based tests will be performed during hospitalization and long-term follow-up: Health-Related Quality of Life Questionnaire (HRQoL), The Functioning in the Chronic Illness Scale (FCIS), and The Adherence in Chronic Diseases Scale (ACDS) [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27] (Tab. 1).…”
Section: Study Endpointsmentioning
confidence: 99%